1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Mei Jung Lai; Ritu Ojha; Mei Hsiang Lin; Yi Min Liu; Hsueh Yun Lee; Tony Eight Lin; Kai Cheng Hsu; Chi Yen Chang; Mei Chuan Chen; Kunal Nepali; Jang Yang Chang; Jing Ping Liou

doi:10.1016/j.ejmech.2018.10.066

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

Mei Jung Lai, Ritu Ojha, Mei Hsiang Lin, Yi Min Liu, Hsueh Yun Lee, Tony Eight Lin, Kai Cheng Hsu, Chi Yen Chang, Mei Chuan Chen, Kunal Nepali, Jang Yang Chang, Jing Ping Liou

研究成果: 雜誌貢獻 › 文章 › 同行評審

28 引文斯高帕斯（Scopus）

摘要

We report structure-activity relationships of 1-arylsulfonyl indoline based benzamides. The benzamide (9) exhibits striking tubulin inhibition with an IC50 value of 1.1 μM, better than that of combretastain A-4 (3), and substantial antiproliferative activity against a variety of cancer cells, including MDR-positive cell lines with an IC50 value of 49 nM (KB), 79 nM (A549), 63 nM (MKN45), 64 nM (KB-VIN10), 43 nM (KB-S15), and 46 nM (KB-7D). Dual inhibitory potential of compound 9 was found as it demonstrated significant inhibitory potential against HDAC1, 2 and 6 in comparison to MS-275 (6). Some key interactions of 9 with the amino acid residues of the active site of tubulin and with amino acid residues of HDAC 1 isoform have been figured out by molecular modeling. Compound 9 also demonstrated significant in vivo efficacy in the human non-small cell lung cancer A549 xenograft model as well as B-cell lymphoma BJAB xenograft tumor model.

原文	英語
頁（從 - 到）	612-630
頁數	19
期刊	European Journal of Medicinal Chemistry
卷	162
DOIs	https://doi.org/10.1016/j.ejmech.2018.10.066
出版狀態	已發佈 - 1月 15 2019

ASJC Scopus subject areas

藥理
藥物發現
有機化學

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.ejmech.2018.10.066

其它文件與鏈接

Link to publication in Scopus

引用此

@article{b165987ce366440e9ca720ade9aa379c,

title = "1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase",

abstract = "We report structure-activity relationships of 1-arylsulfonyl indoline based benzamides. The benzamide (9) exhibits striking tubulin inhibition with an IC50 value of 1.1 μM, better than that of combretastain A-4 (3), and substantial antiproliferative activity against a variety of cancer cells, including MDR-positive cell lines with an IC50 value of 49 nM (KB), 79 nM (A549), 63 nM (MKN45), 64 nM (KB-VIN10), 43 nM (KB-S15), and 46 nM (KB-7D). Dual inhibitory potential of compound 9 was found as it demonstrated significant inhibitory potential against HDAC1, 2 and 6 in comparison to MS-275 (6). Some key interactions of 9 with the amino acid residues of the active site of tubulin and with amino acid residues of HDAC 1 isoform have been figured out by molecular modeling. Compound 9 also demonstrated significant in vivo efficacy in the human non-small cell lung cancer A549 xenograft model as well as B-cell lymphoma BJAB xenograft tumor model.",

keywords = "Benzamide, Cancer, HDAC, Indoline, Tubulin",

author = "Lai, {Mei Jung} and Ritu Ojha and Lin, {Mei Hsiang} and Liu, {Yi Min} and Lee, {Hsueh Yun} and Lin, {Tony Eight} and Hsu, {Kai Cheng} and Chang, {Chi Yen} and Chen, {Mei Chuan} and Kunal Nepali and Chang, {Jang Yang} and Liou, {Jing Ping}",

note = "Funding Information: This research were supported by the Ministry of Science and Technology, Taiwan (grant no. MOST 103-2113-M-038-001-MY3 , 107-2113-M-038-001 ). Publisher Copyright: {\textcopyright} 2018",

year = "2019",

month = jan,

day = "15",

doi = "10.1016/j.ejmech.2018.10.066",

language = "English",

volume = "162",

pages = "612--630",

journal = "CHIM.THER.",

issn = "0223-5234",

publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

AU - Lai, Mei Jung

AU - Ojha, Ritu

AU - Lin, Mei Hsiang

AU - Liu, Yi Min

AU - Lee, Hsueh Yun

AU - Lin, Tony Eight

AU - Hsu, Kai Cheng

AU - Chang, Chi Yen

AU - Chen, Mei Chuan

AU - Nepali, Kunal

AU - Chang, Jang Yang

AU - Liou, Jing Ping

PY - 2019/1/15

Y1 - 2019/1/15

N2 - We report structure-activity relationships of 1-arylsulfonyl indoline based benzamides. The benzamide (9) exhibits striking tubulin inhibition with an IC50 value of 1.1 μM, better than that of combretastain A-4 (3), and substantial antiproliferative activity against a variety of cancer cells, including MDR-positive cell lines with an IC50 value of 49 nM (KB), 79 nM (A549), 63 nM (MKN45), 64 nM (KB-VIN10), 43 nM (KB-S15), and 46 nM (KB-7D). Dual inhibitory potential of compound 9 was found as it demonstrated significant inhibitory potential against HDAC1, 2 and 6 in comparison to MS-275 (6). Some key interactions of 9 with the amino acid residues of the active site of tubulin and with amino acid residues of HDAC 1 isoform have been figured out by molecular modeling. Compound 9 also demonstrated significant in vivo efficacy in the human non-small cell lung cancer A549 xenograft model as well as B-cell lymphoma BJAB xenograft tumor model.

AB - We report structure-activity relationships of 1-arylsulfonyl indoline based benzamides. The benzamide (9) exhibits striking tubulin inhibition with an IC50 value of 1.1 μM, better than that of combretastain A-4 (3), and substantial antiproliferative activity against a variety of cancer cells, including MDR-positive cell lines with an IC50 value of 49 nM (KB), 79 nM (A549), 63 nM (MKN45), 64 nM (KB-VIN10), 43 nM (KB-S15), and 46 nM (KB-7D). Dual inhibitory potential of compound 9 was found as it demonstrated significant inhibitory potential against HDAC1, 2 and 6 in comparison to MS-275 (6). Some key interactions of 9 with the amino acid residues of the active site of tubulin and with amino acid residues of HDAC 1 isoform have been figured out by molecular modeling. Compound 9 also demonstrated significant in vivo efficacy in the human non-small cell lung cancer A549 xenograft model as well as B-cell lymphoma BJAB xenograft tumor model.

KW - Benzamide

KW - Cancer

KW - HDAC

KW - Indoline

KW - Tubulin

UR - http://www.scopus.com/inward/record.url?scp=85056813873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056813873&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2018.10.066

DO - 10.1016/j.ejmech.2018.10.066

M3 - Article

AN - SCOPUS:85056813873

SN - 0223-5234

VL - 162

SP - 612

EP - 630

JO - CHIM.THER.

JF - CHIM.THER.

ER -

1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase

摘要

ASJC Scopus subject areas

UN SDG

存取文件

其它文件與鏈接

指紋

引用此